Use of dasatinib in chronic myeloid leukemia therapy

Use of dasatinib in chronic myeloid leukemia therapy

.

Saved in:

Bibliographic Details
Main Authors:	O. Yu. Vinogradova, A. G. Turkina, N. D. Choroshko
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2008-12-01
Series:	Бюллетень сибирской медицины
Online Access:	https://bulletin.ssmu.ru/jour/article/view/3930
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
by: TI Ionova, et al.
Published: (2017-04-01)

Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
by: Monika Conchon, et al.
Published: (2010-01-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia
by: Avery Watson, M4, et al.
Published: (2025-07-01)

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
by: Andrew Stevenson Joel Chandranesan, et al.
Published: (2018-01-01)

Dasatinib Dose Optimization Based on Therapeutic Drug Monitoring in Patients with Chronic-Phase Chronic Myeloid Leukemia
by: Cheng F, et al.
Published: (2025-05-01)

Dasatinib-induced renal (or chronic) thrombotic microangiopathy in a patient with chronic myeloid leukemia: A case report
by: Ryan Sabour, et al.
Published: (2025-02-01)

A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
by: Samer Alsidawi, et al.
Published: (2014-01-01)

Gelatinous Marrow Transformation in Chronic Myeloid Leukemia Post-Dasatinib Treatment: A Case Report with Review of Literature
by: Gayathri Kini, et al.

Retracted: Treatment of Cancer Gene Changes in Chronic Myeloid Leukemia by Big Data Analysis Platform-Based Dasatinib
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach
by: Shyam Srinivasan
Published: (2024-10-01)

Dasatinib-Induced lymphocytosis and pleural effusion in a patient of chronic myeloid leukemia: A rare Indian case report
by: Ashish Joshi, et al.
Published: (2020-01-01)

Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)
by: EYu Chelysheva, et al.
Published: (2019-03-01)

Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01)

Evolution of therapeutic approaches in patients with chronic myeloid leukemia and T315I mutation
by: A. G. Turkina, et al.
Published: (2024-12-01)

Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results of 2-year follow-up
by: T. I. Ionova, et al.
Published: (2015-10-01)

Arterial Events in Patients with Chronic Myeloid Leukemia Receiving Treatment with Second Generation Tyrosine Kinase Inhibitors
by: GA Gusarova, et al.
Published: (2016-10-01)

Results of asciminib therapy as part of managed access program in patients with chronic myeloid leukemia with T315I mutation
by: A. N. Petrova, et al.
Published: (2025-05-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia
by: AG Turkina, et al.
Published: (2017-07-01)

Results of various somatic mutations detection in patients with chronic myeloid leukemia
by: E. A. Kuzmina, et al.
Published: (2024-12-01)

Cardiovascular and metabolic problems associated with application of second generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
by: O. Y. Vinogradova
Published: (2015-10-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia
by: VA Shuvaev, et al.
Published: (2018-10-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Chronic myeloid leukemia in India
by: John M Goldman
Published: (2013-01-01)

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy
by: O. Yu. Vinogradova, et al.
Published: (2014-07-01)

Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy
by: KM Abdulkadyrov, et al.
Published: (2016-01-01)

Dasatinib for treatment of CAR T-cell therapy-related complications
by: Jakob R Passweg, et al.
Published: (2022-12-01)

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia
by: N. A. Avxentyev, et al.
Published: (2018-08-01)

Acute Myeloid Leukemia with NUP98: : LNP1 Fusion Mimicking Chronic Myeloid Leukemia
by: Haiyang Wang, et al.
Published: (2025-06-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)
by: OA Shukhovv, et al.
Published: (2019-03-01)

Molecular genetics monitoring of tyrosine kinase inhibitor therapy for chronic myeloid leukemia
by: S. I. Kutsev, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

Chronic myeloid leukemia — before and after imatinib (part II)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Retinal infiltration by chronic myeloid leukemia
by: Maïlys Charmasson, et al.
Published: (2025-03-01)

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)

Treatment-Emergent Resistance to Asciminib in Chronic Myeloid Leukemia Patients Due to Myristoyl-Binding Pocket-Mutant of <i>BCR::ABL1/A337V</i> Can Be Effectively Overcome with Dasatinib Treatment
by: Peter Batar, et al.
Published: (2025-02-01)